Our team in Finland has grown significantly this year, and for that, we owe a huge thank you to our excellent clients and the outstanding work delivered by our consultants.
Our Finnish Modelling, Access & Strategy team combines extensive experience from the pharmaceutical industry, consulting, and life sciences. Together, this team brings close to 60 years of expertise across these areas: Katja Nolvi Sami Gabbouj Petri Niinisalo, PhD Ville Perälä
Our backgrounds span across pharma, regulatory and HTA authorities (Fimea, FinCCHTA), as well as strategic consulting. This combination gives us a highly practical understanding of what successful market access and demonstrating the value of medicines truly require.
Both in our previous roles and at Quantify, we have been involved in:
• Finnish PPB and Fimea/Cohere processes
• Pan-Nordic reimbursement applications and strategic consulting
• Building global value dossiers from the ground up
• Developing and localizing health economic models
For us, the most important thing is combining strategic thinking, strong analytical capabilities, and practical execution in a way that helps our clients achieve their goals, and ultimately helps patients gain access to treatments as early as possible.
Feel free to reach out if you would like to discuss market access in Finland and beyond.
